The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.4% in the 4th quarter, Holdings Channel.com reports. The firm owned 72,093 shares of the medical device company’s stock after purchasing an additional 1,668 shares during the period. Motley Fool Asset Management LLC’s holdings in Cooper Companies were worth $6,628,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Fulton Bank N.A. raised its stake in Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after buying an additional 109 shares in the last quarter. Torray Investment Partners LLC increased its holdings in shares of Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares during the last quarter. Mather Group LLC. raised its position in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares in the last quarter. Finally, Greenleaf Trust increased its stake in Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the topic of several research analyst reports. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Piper Sandler reiterated an “overweight” rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Wells Fargo & Company boosted their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Citigroup dropped their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Trading Down 0.0 %

NASDAQ COO opened at $81.23 on Thursday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $16.24 billion, a P/E ratio of 41.66, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The firm has a 50-day moving average price of $88.59 and a 200 day moving average price of $96.72.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.